Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost Dose-Ranging Study in Glaucoma and Ocular Hypertension
NCT01379144Phase 2Completed
- Sponsor
- Viatris
- Start
- Jan 2003
- Primary completion
- Mar 2003
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of latanoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Viatris. Started Jan 2003; status: completed.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01379144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379144.